Literature DB >> 4165739

The role of the kidney in the catabolism of Bence Jones proteins and immunoglobulin fragments.

R D Wochner, W Strober, T A Waldmann.   

Abstract

The role of the kidney in the catabolism of Bence Jones proteins, intact IgG molecules, and isolated L chains, Fab and Fc fragments of IgG, was studied. The proteins were purified, radioiodinated, and their survival times measured in nephrectomized, ureter-severed, and control mice. Active endogenous catabolism was the major factor in overall Bence Jones metabolism since excretion as proteinuria accounted for less than 25% of the total metabolism. The survival times of lambda- and kappa-type human Bence Jones proteins and the Bence Jones protein produced by mice with MPC-2 plasma cell tumor were exceedingly short in both unoperated and ureter-severed mice, with 50% of the injected protein catabolized in from 0.8-1.6 hr. In contrast, the survival of Bence Jones protein was markedly prolonged in nephrectomized animals, with 50% of the injected dose catabolized in from 9 to 17 hr. This ten-fold decrease in catabolic rate indicates that the kidneys are the major site of breakdown of Bence Jones proteins. Similar studies with other proteins indicated that the kidneys are also the major site for catabolism of isolated L chains but not of intact IgG molecules. The Fc immunoglobulin fragment was not catabolized and the Fab fragment only partially catabolized by the kidney. When ureter-severed animals were allowed to develop advanced uremia before being studied, the survival of Bence Jones protein was greatly prolonged, indicating that the catabolic process is impaired in the presence of uremia. The nature of this renal catabolism remains unknown. These observations suggest that the Bence Jones proteins and L chains observed in the urine of patients may reflect only a small fraction of such molecules synthesized by these patients. Furthermore, they provide an explanation for the prolongation of Bence Jones protein survival and the development of Bence Jones proteinemia observed in subjects with multiple myeloma and impaired renal function.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4165739      PMCID: PMC2138312          DOI: 10.1084/jem.126.2.207

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  22 in total

1.  Catabolism of gamma-globulin by the isolated perfused rat liver.

Authors:  S COHEN; A H GORDON; C MATTHEWS
Journal:  Biochem J       Date:  1962-01       Impact factor: 3.857

2.  Metabolic heterogeneity of human gamma-globulin.

Authors:  S COHEN; T FREEMAN
Journal:  Biochem J       Date:  1960-09       Impact factor: 3.857

3.  Physicochemical and immunologic studies of gamma globulins of normal human urine.

Authors:  E C FRANKLIN
Journal:  J Clin Invest       Date:  1959-12       Impact factor: 14.808

4.  Biocolloids in normal human urine. II. Physicochemical and immunochemical characteristics.

Authors:  T WEBB; B ROSE; A H SEHON
Journal:  Can J Biochem Physiol       Date:  1958-11

5.  Site of catabolism of serum albumin.

Authors:  D GITLIN; J R KLINENBERG; W L HUGHES
Journal:  Nature       Date:  1958-04-12       Impact factor: 49.962

6.  Behaviour of 14C- and 131I-labelled plasma proteins in the rat.

Authors:  R M CAMPBELL; D P CUTHBERTSON; C M MATTHEWS; A S MCFARLANE
Journal:  Int J Appl Radiat Isot       Date:  1956-07

7.  Increase of L-chain proteins in the sera of patients with systemic lupus erythematosus and the synovial fluids of patients with peripheral rheumatoid arthritis.

Authors:  W V Epstein; M Tan
Journal:  Arthritis Rheum       Date:  1966-10

8.  The transmission of immunity from mother to young and the catabolism of immunoglobulins.

Authors:  F W Brambell
Journal:  Lancet       Date:  1966-11-19       Impact factor: 79.321

9.  Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism.

Authors:  R D Wochner; G Drews; W Strober; T A Waldmann
Journal:  J Clin Invest       Date:  1966-03       Impact factor: 14.808

10.  Metabolism of human immunoglobulin D (IgD).

Authors:  G N Rogentine; D S Rowe; J Bradley; T A Waldmann; J L Fahey
Journal:  J Clin Invest       Date:  1966-09       Impact factor: 14.808

View more
  68 in total

1.  Serum disappearance and catabolism of homologous immunoglobulin fragments in rats.

Authors:  W P Arend; F J Silverblatt
Journal:  Clin Exp Immunol       Date:  1975-12       Impact factor: 4.330

2.  Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.

Authors:  E A Johns; R Turner; E H Cooper; I C Maclennan
Journal:  J Clin Pathol       Date:  1986-08       Impact factor: 3.411

Review 3.  Immuno-positron emission tomography in cancer models.

Authors:  Smitha Reddy; Matthew K Robinson
Journal:  Semin Nucl Med       Date:  2010-05       Impact factor: 4.446

Review 4.  Serum free light chain assessment in monoclonal gammopathy and kidney disease.

Authors:  Colin A Hutchison; Kolitha Basnayake; Paul Cockwell
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

5.  The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor.

Authors:  R P Junghans; C L Anderson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

6.  Lymphoproliferative disease-related mixed cryoglobulinemia treated with rituximab and prednisolone.

Authors:  Yoshinosuke Shimamura; Hideki Takizawa; Yayoi Ogawa; Hajime Sakai; Akane Ryu; Norihito Moniwa; Koichi Hasegawa; Nobuyuki Ura
Journal:  CEN Case Rep       Date:  2014-08-27

Review 7.  Light chains removal by extracorporeal techniques in acute kidney injury due to multiple myeloma: a position statement of the Onconephrology Work Group of the Italian Society of Nephrology.

Authors:  P Fabbrini; K Finkel; M Gallieni; G Capasso; M Cavo; A Santoro; S Pasquali
Journal:  J Nephrol       Date:  2016-10-18       Impact factor: 3.902

Review 8.  Paraprotein-Related Kidney Disease: Kidney Injury from Paraproteins-What Determines the Site of Injury?

Authors:  Mona Doshi; Amit Lahoti; Farhad R Danesh; Vecihi Batuman; Paul W Sanders
Journal:  Clin J Am Soc Nephrol       Date:  2016-08-15       Impact factor: 8.237

9.  The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia.

Authors:  T A Waldmann; W Strober; R P Mogielnicki
Journal:  J Clin Invest       Date:  1972-08       Impact factor: 14.808

10.  Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmacokinetics in dogs.

Authors:  V P Butler; D H Schmidt; T W Smith; E Haber; B D Raynor; P Demartini
Journal:  J Clin Invest       Date:  1977-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.